ForexProsThe Exchange Rates are powered by Forexpros - The Leading Financial Portal.

BCLI: DSMB Recommends Phase 2 ALS Trial Continue as Planned; Data in Mid-2016…

December 2, 2015 | By | Reply More

On November 16, 2015, BrainStorm Cell Therapeutics (BCLI) filed form 10-Q with financial results for the third quarter of 2015. On August 10, 2015, BrainStorm announced the completion of enrollment of 48 patients in the company’s ongoing, randomized, double blind, placebo controlled Phase 2 clinical trial of NurOwn™ in amyotrophic lateral sclerosis (ALS).

Options News and Information on Yahoo! Finance

Tags: , , , , , , , ,

Category: Options

Leave a Reply